Catheter Precision Corporation (VTAK) - צמיחת רווח נקי למניה אחת לשנה הנוכחית

Catheter Precision creates unique navigators for arrhythmia therapy, utilizing patents to protect margins. Despite a lack of scale when competing with corporate behemoths, the company is betting on system ergonomics. The YoY EPS dynamics on GURU.Markets visualize this trajectory, where the latest parameter is 0.00. The strategy will culminate in increasing ablation precision through the sale of specialized software and catheters.

This indicator calculates the percentage deviation of current earnings per share from the value of the same period last year. This metric allows for an assessment of business resilience to market shocks and the pace of capital scaling on a daily basis. The high-tech team of biomedical specialists at Catheter Precision (VTAK) ensures margin growth, which is clearly reflected in the history of annual net income growth per share.